Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × NETWORK × Stomach Neoplasms × Clear all

Phase

Phase 2 15 Phase NA 6 Phase 3 2 Phase 1/2 2 Phase 1 2 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 30 INDUSTRY 12 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Lymphoma 3 Leukemia 2 Colorectal Neoplasms 2 Xerostomia 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Tongue Neoplasms 1 Stomach Neoplasms 1 Sezary Syndrome 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Salivary Gland Neoplasms 1 Recurrent Squamous Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Previously Treated Non-Small Cell Lung Cancer 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Neurofibrosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Mycosis Fungoides 1 Multiple Myeloma 1 Mouth Neoplasms 1

Interventions

Oxaliplatin 1 Leucovorin 1 Gastrectomy 1 Fluorouracil 1 Epirubicin 1 Docetaxel 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01924819 2025-03-04

TOPGEAR

Australasian Gastro-Intestinal Trials Group

Phase 2/3 Active not recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡